Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-03

FDA Approved: ALMOTRIPTAN — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original application for Almotriptan, a generic treatment for acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALMOTRIPTAN (almotriptan)

Snippet

ORIG AP for ALMOTRIPTAN (ALMOTRIPTAN)